Exploratory study of (18)F-fluciclovine pet/ct for response assessment to docetaxel in patients with metastatic castration-resistant prostate cancer

Monitoring therapeutic response in patients with metastatic castration-resistant prostate cancer (mCRPC) can be challenging. We set out to determine if (18)F-fluciclovine PET/CT could be a useful imaging biomarker for response to docetaxel chemotherapy in patients with mCRPC. Seven patients with mCR...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Nucl Med Mol Imaging
Main Authors: Akintayo, Akinyemi A, Bilen, Mehmet A, Abiodun-Ojo, Olayinka A, Kucuk, Omer, Carthon, Bradley, Chen, Zengjia, Jani, Ashesh B, Parent, Ephraim E, Schuster, David M
Formato: Artigo
Idioma:Inglês
Publicado em: e-Century Publishing Corporation 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8255212/
https://ncbi.nlm.nih.gov/pubmed/34235000
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados